Iwakura, T.; Yasu, T.; Tomoe, T.; Ueno, A.; Sugiyama, T.; Otani, N.; Kawamoto, S.; Nakajima, H.
Effect of Pemafibrate on Hemorheology in Patients with Hypertriglyceridemia and Aggravated Blood Fluidity Associated with Type 2 Diabetes or Metabolic Syndrome. J. Clin. Med. 2023, 12, 1481.
https://doi.org/10.3390/jcm12041481
AMA Style
Iwakura T, Yasu T, Tomoe T, Ueno A, Sugiyama T, Otani N, Kawamoto S, Nakajima H.
Effect of Pemafibrate on Hemorheology in Patients with Hypertriglyceridemia and Aggravated Blood Fluidity Associated with Type 2 Diabetes or Metabolic Syndrome. Journal of Clinical Medicine. 2023; 12(4):1481.
https://doi.org/10.3390/jcm12041481
Chicago/Turabian Style
Iwakura, Tomohiro, Takanori Yasu, Takashi Tomoe, Asuka Ueno, Takushi Sugiyama, Naoyuki Otani, Shinya Kawamoto, and Hiroyuki Nakajima.
2023. "Effect of Pemafibrate on Hemorheology in Patients with Hypertriglyceridemia and Aggravated Blood Fluidity Associated with Type 2 Diabetes or Metabolic Syndrome" Journal of Clinical Medicine 12, no. 4: 1481.
https://doi.org/10.3390/jcm12041481
APA Style
Iwakura, T., Yasu, T., Tomoe, T., Ueno, A., Sugiyama, T., Otani, N., Kawamoto, S., & Nakajima, H.
(2023). Effect of Pemafibrate on Hemorheology in Patients with Hypertriglyceridemia and Aggravated Blood Fluidity Associated with Type 2 Diabetes or Metabolic Syndrome. Journal of Clinical Medicine, 12(4), 1481.
https://doi.org/10.3390/jcm12041481
